Φορτώνει......
Phase II Clinical and Pharmacologic Study of Radiation Therapy and Carboxyamido-triazole (CAI) in Adults with Newly Diagnosed Glioblastoma Multiforme(1)
INTRODUCTION: Carboxyamido-triazole (CAI) is a synthetic inhibitor of non-voltage-gated calcium channels that reversibly inhibits angiogenesis, tumor cell proliferation, and metastatic potential. This study examined the efficacy, safety and pharmacokinetics of oral CAI in the treatment of patients w...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , , , , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2006
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3963813/ https://ncbi.nlm.nih.gov/pubmed/17080256 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-006-9023-6 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|